What Is rPPG? How Insurers Use Camera-Based Health Screening

rPPG insurance health screening represents a fundamental rethinking of how life insurance carriers gather physiological evidence during the underwriting process. Remote photoplethysmography---rPPG---is a camera-based method for measuring vital signs without physical contact, sensors, or wearable devices. An applicant looks at a smartphone or webcam for 30 to 90 seconds, and algorithms extract heart rate, respiratory rate, heart rate variability, blood oxygen saturation, and blood pressure estimates from subtle, sub-pixel color variations in the facial skin caused by blood flow. For an industry that has relied on paramedical examiners, blood draws, and multi-day laboratory turnarounds for over a century, the implications are significant.

"EHR release rates rose from just 11% in 2020 to 52% in 2025, spanning all use cases. 74% of EHRs are delivered in less than one day." --- MIB, 2025

The Science Behind rPPG Insurance Health Screening

Remote photoplethysmography is rooted in a straightforward physiological principle. With each cardiac cycle, the heart pumps blood through the arterial system, causing transient changes in blood volume within the capillary beds beneath the skin. These volumetric fluctuations produce microscopic color changes on the skin surface---imperceptible to the human eye but detectable by a digital camera sensor. By isolating and analyzing these pixel-level color variations across a sequence of video frames, rPPG algorithms reconstruct the underlying physiological signals.

The technology has evolved through three distinct methodological generations:

Signal processing approaches. Early rPPG methods relied on blind source separation techniques---Independent Component Analysis (ICA) and Principal Component Analysis (PCA)---to isolate the blood volume pulse signal from noise, motion artifacts, and ambient lighting changes. These methods established the feasibility of camera-based vital sign measurement but were sensitive to environmental conditions.

Model-based approaches. Subsequent methods incorporated physical models of light-skin interaction, using knowledge of how light penetrates and reflects from tissue at different wavelengths. These approaches improved robustness by leveraging the known optical properties of hemoglobin absorption.

Deep learning approaches. Current state-of-the-art methods employ convolutional neural networks, temporal convolutional networks, and transformer architectures trained on large datasets of synchronized video and reference sensor data. A comprehensive review published in npj Digital Medicine (2025) examining the role of face regions in rPPG found that machine learning-based approaches outperform traditional methods under motion artifacts and poor lighting, achieving mean absolute error below 1.0 bpm on benchmark datasets.

The vital signs extractable through rPPG include:

Vital Sign	Measurement Principle	Current Accuracy Level	Insurance Relevance
Heart rate	Blood volume pulse frequency	MAE of 1.061 bpm vs. ECG in research studies	Direct risk indicator; resting heart rate correlates with cardiovascular mortality
Respiratory rate	Modulation of cardiac signal by breathing	96% agreement with clinical methods in 963-patient trial	Indicator of cardiopulmonary function; abnormal rates flag underlying conditions
Heart rate variability (HRV)	Beat-to-beat interval variation	Strong correlation with contact-based reference	Marker of autonomic nervous system health; associated with all-cause mortality
Blood oxygen saturation (SpO2)	Ratio of oxygenated to deoxygenated hemoglobin via dual-wavelength analysis	Under active refinement for camera-based measurement	Screening indicator for respiratory and circulatory conditions
Blood pressure estimate	Pulse transit time and waveform morphology analysis	MAE of 2.35 mmHg (SBP) and 1.69 mmHg (DBP) in controlled settings	Primary cardiovascular risk factor; central to mortality risk classification

Applications in Insurance Underwriting

Filling the Accelerated Underwriting Evidence Gap

The most immediate insurance application of rPPG addresses a specific structural problem. As of 2025, 59 percent of individual life insurance applications qualify for accelerated underwriting, according to Gen Re's Next Gen Underwriting Survey. These applicants are deemed eligible to bypass the paramedical exam based on age, face amount, and health history criteria. However, waiving the exam also eliminates the vital sign data---blood pressure, pulse rate---that the exam would have captured.

This creates an evidence gap. Underwriters evaluating accelerated-eligible applicants rely on prescription histories, electronic health records, motor vehicle reports, and self-reported health information. What they lack is objective, contemporaneous physiological measurement. rPPG fills this gap by capturing vital sign data within the digital application workflow, requiring nothing more than the applicant's own device camera.

Improving Placement Rates Through Friction Reduction

Gen Re's 2025 survey documented a direct relationship between underwriting speed and policy placement. Applications processed through fully automated workflows achieved an 86 percent placement rate, compared to 63 percent through traditional underwriting---a 23-percentage-point differential. Every point of friction in the underwriting process represents potential applicant abandonment and lost premium revenue.

The paramedical exam is among the highest-friction evidence requirements in the underwriting process. It requires scheduling a mobile examiner, coordinating the applicant's availability, conducting a 20-to-45-minute in-person session involving blood draws and urine collection, and waiting 3 to 10 business days for laboratory results. rPPG replaces the vital sign measurement component of this process with a 30-to-90-second video session that produces results in minutes.

Supporting Direct-to-Consumer Distribution

The direct-to-consumer life insurance channel, growing at a 6.75 percent CAGR through 2034, depends on end-to-end digital experiences. When an applicant purchasing coverage through a mobile app is redirected to schedule an in-person exam, the digital journey fractures. rPPG preserves the continuity of the digital workflow by embedding physiological measurement within the application interface itself.

Enabling Group and Voluntary Benefit Screening

In employer-sponsored group life and voluntary benefit programs, per-certificate paramedical exam costs are prohibitive for most coverage levels. rPPG offers a mechanism to gather individual physiological data at scale for simplified issue and guarantee issue products, potentially enabling more refined risk classification within group portfolios without the logistical overhead of coordinating examinations across an employer's workforce.

Research and Clinical Evidence

The scientific literature supporting rPPG has expanded rapidly. A state-of-the-art survey published in WIREs Data Mining and Knowledge Discovery (Sakib, 2025) documented that 81.4 percent of rPPG research was published between 2015 and 2025, reflecting accelerating academic and commercial interest.

Heart rate measurement has achieved the highest level of validation. A clinical study published in Bioengineering (2025) validated rPPG-derived pulse rate in cardiovascular disease patients, reporting a mean absolute error of 1.061 bpm, root-mean-squared error of 2.845 bpm, and Pearson correlation of 0.962 against ECG reference. A systematic review in npj Digital Medicine (2025) analyzing 70 studies found that forehead and cheek regions provide superior measurement accuracy, with machine learning approaches achieving MAE and RMSE below 1.0 on standard datasets.

Respiratory rate measurement was validated in a hospital-based clinical trial published in the Journal of Clinical Monitoring and Computing (2022) involving 963 patients, demonstrating 96 percent agreement with standard clinical methods.

Blood pressure estimation represents the most active area of research advancement. A study published in Applied Intelligence (December 2024) reported video-based beat-by-beat blood pressure monitoring with mean absolute error of 2.35 mmHg for systolic and 1.69 mmHg for diastolic blood pressure under controlled conditions. A 2024 study at Singapore General Hospital achieved a mean absolute percentage error of 7.52 percent for diastolic blood pressure prediction using deep learning models. Research presented at WACV 2025 demonstrated transfer learning approaches that train models on contact PPG data and fine-tune them on rPPG signals, improving generalization across populations.

Robustness research published in npj Digital Medicine (2025) examined rPPG reliability under low illumination and elevated heart rates, finding that five of eight tested methods experienced statistically significant performance declines at elevated heart rates. The authors characterized these as engineering challenges with identifiable solutions---improved temporal modeling and motion-robust architectures---rather than fundamental limitations of the approach.

A comprehensive review published in Frontiers in Digital Health (2025) surveyed rPPG methods for health assessment, cataloging applications spanning clinical monitoring, telemedicine, occupational health, and biometric screening, and concluded that the technology has matured to the point of practical deployment across multiple domains.

The Future of rPPG in Insurance

The trajectory of rPPG adoption in insurance will be shaped by three dynamics operating in parallel.

Expanding the measurable parameter set. Current commercial implementations focus on heart rate, respiratory rate, HRV, and SpO2, with blood pressure estimation as an emerging capability. Research into hemoglobin concentration estimation, stress indicators derived from autonomic nervous system metrics, and atrial fibrillation detection from camera-derived signals points toward a future where rPPG captures a broader physiological profile from a single video session.

Improving real-world robustness. The gap between laboratory accuracy and field performance is narrowing with each generation of deep learning models. Advances in motion compensation, ambient lighting adaptation, and cross-demographic calibration are addressing the practical challenges identified in clinical literature. As these improvements compound, carrier confidence in deploying rPPG across diverse applicant populations will grow.

Regulatory integration. The NAIC's Accelerated Underwriting Working Group is developing regulatory guidance for alternative evidence-gathering methods. As this guidance crystallizes, it will provide carriers with a clearer framework for incorporating rPPG data into underwriting decisions. The NAIC's broader AI governance initiatives---including the anticipated 2026 AI evaluation pilot program---will also shape how algorithmic processing of rPPG signals is governed within carrier operations.

The convergence of these forces points toward rPPG becoming a standard component of the underwriting evidence hierarchy within the next two to three years---not as a replacement for all medical evidence, but as a low-friction, high-value source of objective physiological data that integrates naturally into digital-first underwriting workflows.

Frequently Asked Questions

What vital signs can rPPG measure for insurance underwriting?

rPPG can measure heart rate, respiratory rate, heart rate variability, and blood oxygen saturation with strong research support. Blood pressure estimation is an advancing capability, with recent research achieving mean absolute error as low as 2.35 mmHg for systolic blood pressure under controlled conditions. The range of measurable parameters continues to expand as deep learning models are applied to the underlying physiological signals.

How does rPPG compare to a paramedical exam?

rPPG replaces the vital sign measurement component of a paramedical exam---blood pressure, pulse, respiratory rate---in a 30-to-90-second video session rather than a 20-to-45-minute in-person appointment. It does not replace blood chemistry, urinalysis, or other fluid-based tests. For the 59 percent of applicants who qualify for accelerated underwriting where fluid testing is already waived, rPPG provides objective physiological data that would otherwise be absent from the file.

Does skin tone or lighting affect rPPG accuracy?

Published research identifies ambient lighting and skin tone variability as factors that influence rPPG performance. A 2025 study in npj Digital Medicine specifically examined performance under low illumination, finding measurable impact on some methods. However, deep learning approaches consistently outperform traditional signal processing methods under challenging conditions, and ongoing research into cross-demographic calibration and lighting compensation is progressively reducing these sensitivities.

How do carriers integrate rPPG into existing underwriting platforms?

rPPG technology is typically delivered as an API-based service. During the digital application process, the applicant is prompted to complete a brief video session using their device's front-facing camera. The video is processed through signal extraction algorithms, and the resulting vital sign readings are returned as structured data formatted for ingestion by the carrier's automated decisioning engine or underwriting workbench. No hardware beyond the applicant's existing smartphone or webcam is required.

---

rPPG technology is reshaping how carriers think about physiological evidence in underwriting. Circadify has developed contactless vital sign measurement designed for integration into insurance underwriting platforms, enabling carriers to capture objective health data within accelerated workflows. Explore how rPPG-based vitals integrate with your underwriting platform.